Patients with completely resected nongenitourinary low-risk embryonal rhabdomyosarcoma are candidates for reduced duration low-intensity chemotherapy

Gianni Bisogno, Joerg Fuchs, Roshni Dasgupta, Andrea Ferrari, Josephine H. Haduong, Timothy Rogers, David O. Walterhouse, Beatrice Coppadoro, Wei Xue, Christian Vokuhl, Douglas S. Hawkins, Guido Seitz, Johannes H.M. Merks, Monika Sparber-Sauer, Rajkumar Venkatramani

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Patients with completely resected nongenitourinary low-risk embryonal rhabdomyosarcoma are candidates for reduced duration low-intensity chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences